Leadership is entering a new era, shaped by the rise of agentic AI systems capable of taking initiative, making decisions, ...

The three-year study – led by mental health data science company Akrivia Health in partnership with Cardiff University – will ...

Following his return from San Francisco and the JP Morgan Healthcare conference last month, editor-in-chief Jonah Comstock ...

The approval of Exdensur (depemokimab) for severe asthma and chronic rhinosinusitis with nasal polyps by the European ...

The drug – called SPL026 – was originally developed by UK firm Small Pharma, which was acquired by Canadian firm Cybin in ...

The latest readout, from the COMP006 study, showed that two doses of the highest, 25mg dose of COMP360, given in a controlled environment with psychological support from a trained therapist, were ...

Roche has appointed leading Australian cancer researcher Prof Mark Dawson to lead its pharma Research and Early Development (pRED) division from its recently opened unit in Basel, Switzerland.

Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...

Storage specialist appoints new chief executive. Astoriom, a UK specialist in R&D sample storage, named Will Edwards as CEO.

Politico has said that O'Neill and HHS General Counsel Mike Stuart are leaving their current roles as part of a broader shake ...

The Medicines and Healthcare products Regulatory Agency (MHRA) is hoping to address a critical regulatory issue for medical ...

One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned ...